Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Search results for "gene delivery platform"
Home
Samyang Biopharm’s NanoReady Delivers 20x mRNA Payload for Personalized Cancer Vaccines
Samyang Biopharm announced on the 20th that nonclinical study results for its proprietary gene delivery platform, "NanoReady," designed for...
08/24/2026, 05:24 ET
Turning Off Cancer Signals: New Precision Drug Stops Tumors Without Harming Healthy Cells
South Korean researchers have developed a novel anticancer approach capable of selectively turning off specific cellular "switches" that drive tumor...
09/13/2026, 10:34 ET
Hansol Hospital Reaches 200 Single-Port Robotic Surgeries in 8 Months
Hansol Hospital, a colorectal specialty hospital designated by the Ministry of Health and Welfare, announced Sept.
09/09/2026, 03:29 ET
Regenerative Technique Aims to Solve Rotator Cuff Re-Tears by Rebuilding the Tendon-Bone Junction
When surgeons reattach a torn shoulder tendon to the bone, a frustrating setback often occurs over time: the repair...
08/24/2026, 05:24 ET
Moderna’s Landmark mRNA Cancer Vaccine Phase 3 Success Spotlights Korean Biotech Ties
Positive late-stage clinical results for a personalized messenger RNA cancer vaccine developed by Moderna and Merck are...
08/21/2026, 04:14 ET
KHIDI Accelerates Biohealth R&D Support with Agency-Wide AI Transformation
Staff supporting biohealth research and development (R&D) spend substantial time navigating and analyzing massive...
08/12/2026, 11:04 ET
Alteogen Signs $365 Million Licensing Deal for Subcutaneous Drug Delivery Platform ALT-B4
Biotechnology firm Alteogen has signed an exclusive technology-transfer agreement worth up to $365 million...
08/09/2026, 10:45 ET
CAR-T Without Extracting Patient Cells? J&J Makes $785 Million Bet on In Vivo Therapy
Johnson & Johnson (J&J) is investing more than $785 million (approximately 1.11 trillion won) in next-generation "in...
08/09/2026, 09:45 ET
Olix Obesity Candidate Reduces Monkeys’ Visceral Fat by 29.2%, Outperforming Global Rival
Olix announced on July 30 that its obesity drug candidate, "OLX501A," significantly outperformed a global rival...
08/02/2026, 06:52 ET
AI Cancer Gene Analysis and 810 Billion-Won Tech Export Lead South Korea's Top 30 Health Care R&D Achievements
The Ministry of Health and Welfare and the Korea Health Industry Development Institute announced on the 8th that they...
07/14/2026, 05:36 ET
1
2
Next